14 Results for "

SHMT2

" in MedChemExpress (MCE) Product Catalog:
Products (14)

14 Results for "SHMT2" in MCE Product Catalog:

  • Isoforms Recommended:
  • Targets Recommended:
Cat. No.: HY-176542
CAS No.: 3030718-42-1
Target:  

HDAC YAP

Research Areas:  

Cancer

TD034 is a selective, reversible and noncovalent HDAC11 inhibitor with an IC50 of 5.1 nM and a Ki of 1.5 nM. TD034 does not inhibit other HDACs or sirtuins. TD034 inhibits the defatty acylation of SHMT2 (HDAC11 substrate). TD034 decreases the YAP1 level via HDAC11 inhibition. TD034 can be used for the study of lung cancer .
loading...
    loading...
Cat. No.: HY-129226
CAS No.: 2102681-49-0
Purity:  99.60%
Target:  

SHMT

Research Areas:  

Endocrinology Cancer

SHMT-IN-2 is a stereo specific inhibitor of human SHMT1/2 with IC50 values of 13 nM and 66 nM for SHMT1 and SHMT2, respectively. SHMT-IN-2 can block the growth of many human cancer cells, and has sensitivity for B-cell lymphomas .
loading...
    loading...
Cat. No.: HY-178432
Research Areas:  

Cancer

SHMT2-IN-1 is a potent serine hydroxymethyltransferase 2 (SHMT2) inhibitor with an IC50 of 1.21 μM and a KD of 10.6 μM. SHMT2-IN-1 binds to the folate binding site of SHMT2. SHMT2-IN-1 also inhibits SHMT1 with an IC50 of 1.83 μM. SHMT2-IN-1 can inhibit cancer cells proliferation, migration and invasion. SHMT2-IN-1 can induce cells apoptosis and ROS production and cause G2/M phase arrest. SHMT2-IN-1 can be used for the research of cancer, such as esophageal cancer .
loading...
    loading...
Cat. No.: HY-148545
CAS No.: 330638-43-2
Target:  

SHMT

Research Areas:  

Cancer

SHMT-IN-3 (Hit 1) is a SHMT1 and SHMT2 inhibitor with an IC50 of 0.53 µM for human SHMT1. SHMT-IN-3 exhibits noncompetitive inhibition against serine .
loading...
    loading...
Cat. No.: HY-RS12877
Research Areas:  

Others

SHMT2 Human Pre-designed siRNA Set A contains three designed siRNAs for SHMT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS17061
Research Areas:  

Others

Shmt2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Shmt2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS23505
Research Areas:  

Others

Shmt2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Shmt2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P701976
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: SHMT2; Serine hydroxymethyltransferase; mitochondrial; SHMT; Glycine hydroxymethyltransferase; Serine methylase
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P701977
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: SHMT2; Serine hydroxymethyltransferase; mitochondrial; SHMT; Glycine hydroxymethyltransferase; Serine methylase
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P88109
Synonyms: GLYA; HEL-S-51e; NEDCASB; SHMT

Host:  

Mouse

Application:  

IHC-P

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-P88109A
Synonyms: GLYA; HEL-S-51e; NEDCASB; SHMT

Host:  

Mouse

Application:  

IHC-P

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-182284
Anticancer agent 310 is an antitumor agent. Anticancer agent 310 releases nitric oxide to induce mitochondrial ROS burst, triggers mitochondrial dysfunction and activates the Bax/Bcl-2-Cyt c-Caspase-9/Caspase-3 apoptotic pathway. Anticancer agent 310 also reduces the levels of SHMT2 and MTHFD2, decreases the ratios of NADPH/NADP + and GSH/GSSG, thereby disrupting redox homeostasis and exacerbating intracellular ROS accumulation. Anticancer agent 310 can be used in research related to gastric cancer .
loading...
    loading...
Cat. No.: HY-182019
HDAC11-IN-5 is a selective, potent and orally active HDAC11 inhibitor with an IC50 of 0.021 μM. HDAC11-IN-5 increases fatty acylation levels of substrate SHMT2 in AML cells. HDAC11-IN-5 induces apoptosis, G1 phase cell cycle arrest, ferroptosis, ROS production and terminal myeloid differentiation in AML cells. HDAC11-IN-5 demonstrates anti-tumor potency in an MLL-AF9-induced mouse AML model. HDAC11-IN-5 can be used for the research of cancer, such as acute myeloid leukemia .
loading...
    loading...
Cat. No.: HY-177092
CAS No.: 2294820-23-6
AGF347 is a potent and multi-targeted antifolate that targets serine hydroxymethyltransferase (SHMT)2 in the mitochondria and SHMT1 in the cytosol, and inhibits de novo purine biosynthesis. AGF347 induces apoptosis, inhibits mTOR signaling, decreases GSH pools, and increases ROS. AGF347 inhibits proliferation of Cisplatin (HY-17394) sensitive and resistant epithelial ovarian cancer (EOC) cells. AGF347 exhibits antitumor efficacy in SKOV3 EOC xenograft mouse models. AGF347 can be used for ovarian cancer research [2].
loading...
    loading...
  • 1